期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Application of multiple Roux-en-Y hepaticojejunostomy reconstruction by formation of bile hilar duct lake in the operation of hilar cholangiocarcinoma 被引量:2
1
作者 Xiao-Jun Yang Xiao-Hua dong +5 位作者 Shi-Yong Chen Biao Wu Yu He bao-long dong Bing-Qiang Ma Peng Gao 《World Journal of Clinical Cases》 SCIE 2020年第1期68-75,共8页
BACKGROUND Hilar cholangiocarcinoma is the most common malignant tumor of the extrahepatic bile duct.Until now,radical resection has been the most effective method for the long-term survival of patients with the disea... BACKGROUND Hilar cholangiocarcinoma is the most common malignant tumor of the extrahepatic bile duct.Until now,radical resection has been the most effective method for the long-term survival of patients with the disease.However,many problems have emerged in the field of hepatobiliary surgery for a long time,including complex surgical procedures,low resection rate,and postoperative complications.We have adopted the“multiple Roux-en-Y hepaticojejunostomy reconstruction by formation of a bile duct lake”technique in the treatment of hilar cholangiocarcinoma since 2008,and obtained satisfactory short-and longterm results.AIM To examine the feasibility of the application of multiple Roux-en-Y hepaticojejunostomy reconstruction by formation of a bile duct lake in the operation of hilar cholangiocarcinoma METHODS A retrospective analysis was performed for the clinical data,surgical methods,and results of 76 patients with hilar cholangiocarcinoma who were treated with hilar bile duct lake-forming multiple Roux-en-Y hepaticojejunostomy reconstruction at Gansu Provincial Hospital.RESULTS In all 76 cases,the operation was successful and no operative death occurred.The mean(range)operation time was 215.4±53.5 min(124–678 min),and the amount of bleeding during the operation was 428.2±63.8 mL(240–2200 mL).The overall 1-year survival rate was 78.9%,and the 3-year survival rate was 32.8%.CONCLUSION The multiple Roux-en-Y hepaticojejunostomy reconstruction technique with formation of a bile duct lake is safe and effective for the surgical treatment of hilar cholangiocarcinoma. 展开更多
关键词 Hilar cholangiocarcinoma Bile duct lake HEPATICOJEJUNOSTOMY
下载PDF
Giant hemangioma of the caudate lobe of the liver with surgical treatment:A case report 被引量:1
2
作者 Xin-Xin Wang bao-long dong +3 位作者 Biao Wu Shi-Yong Chen Yu He Xiao-Jun Yang 《World Journal of Clinical Cases》 SCIE 2021年第21期5980-5987,共8页
BACKGROUND Caudate lobe hemangioma of the liver is relatively rare.Due to the unique anatomical location of the caudate lobe,the caudate lobectomy accounts for only 0.5%to 4%of hepatic resection,which is difficult to ... BACKGROUND Caudate lobe hemangioma of the liver is relatively rare.Due to the unique anatomical location of the caudate lobe,the caudate lobectomy accounts for only 0.5%to 4%of hepatic resection,which is difficult to operate and takes a long time,and even has many postoperative complications.CASE SUMMARY A 34-year-old female presented with a 1 year history of intermittent pain in the right side of the waist without obvious inducement.All laboratory blood tests were within normal limits.Indocyanine green 15 min retention was rated 2.9%,and Child-Pugh was rated A.Computed tomography and magnetic resonance imaging diagnosed giant hemangioma of the caudate lobe with hemangioma of left lobe of liver.After discussion,surgical treatment was performed,which lasted 410 min,with intraoperative bleeding of about 600 mL and postoperative pathological findings of cavernous hemangioma.There were no obvious postoperative complications,and the patient was discharged 10 d after surgery.CONCLUSION Caudate lobectomy is difficult due to its special anatomical location.Under the condition of fully exposing the anatomy of the first porta hepatis,the second porta hepatis,the third porta hepatis,the fourth porta hepatis and middle hepatic vein and combining with the Pringle maneuver,caudate lobectomy can be performed in a precise and safe process. 展开更多
关键词 Caudate lobe hemangioma Caudate lobectomy Case report
下载PDF
Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma 被引量:1
3
作者 Hui-Qi Zhao bao-long dong +5 位作者 Min Zhang Xiao-Hua dong Yu He Shi-Yong Chen Biao Wu Xiao-Jun Yang 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2020年第3期276-288,共13页
BACKGROUND The kinesin superfamily protein member KIF21B plays an important role in regulating mitotic progression;however,the function and mechanisms of KIF21B in cancer,particularly in hepatocellular carcinoma(HCC),... BACKGROUND The kinesin superfamily protein member KIF21B plays an important role in regulating mitotic progression;however,the function and mechanisms of KIF21B in cancer,particularly in hepatocellular carcinoma(HCC),are unknown.AIM To explore the role of KIF21B in hepatocellular carcinoma and its effect on prognosis after hepatectomy.METHODS First,data on the differential expression of KIF21B in patients with HCC from The Cancer Genome Atlas database was analyzed.Subsequently,the expression levels of KIF21B in HCC cell lines and hepatocytes were detected by reverse transcription-polymerase chain reaction,and its biological effect on BEL-7404 cells was evaluated by KIF21B knockdown.Immunohistochemical analysis was used to validate the differential expression of KIF21B in HCC tissues and adjacent normal tissues from 186 patients with HCC after hepatectomy.The Kaplan-Meier method was used to assess prognosis significance.RESULTS KIF21B expression levels were significantly higher in HCC tissues than in corresponding adjacent normal tissues.The expression levels of KIF21B in four HCC cell lines were higher than that in normal liver cells.Functional experiments showed that KIF21B knockdown remarkably suppressed cell proliferation and induced apoptosis.Moreover,immunohistochemistry results are consistent with The Cancer Genome Atlas analysis,with KIF21B expression levels being increased in HCC tissues compared to adjacent normal tissues.Univariate and multivariate analyses revealed KIF21B as an independent risk factor for overall survival and disease-free survival in patients with HCC after hepatectomy.CONCLUSION Taken together,our results provide evidence that KIF21B plays an important role in HCC progression and may be a potential diagnostic and prognostic marker for HCC. 展开更多
关键词 Hepatocellular carcinoma KIF21B PROLIFERATION APOPTOSIS PROGNOSIS
下载PDF
Primary intestinal extranodal natural killer/T-cell lymphoma, nasal type: A case report
4
作者 bao-long dong Xiao-Hua dong +2 位作者 Hui-Qi Zhao Peng Gao Xiao-Jun Yang 《World Journal of Clinical Cases》 SCIE 2020年第1期234-241,共8页
BACKGROUND Primary intestinal extranodal natural killer/T-cell lymphoma,nasal type(PIENKTCL)is a rare non-Hodgkin’s lymphoma(NHL)subtype,and its prognosis is extremely poor.Clinical characteristics of the disease are... BACKGROUND Primary intestinal extranodal natural killer/T-cell lymphoma,nasal type(PIENKTCL)is a rare non-Hodgkin’s lymphoma(NHL)subtype,and its prognosis is extremely poor.Clinical characteristics of the disease are not obvious and easily misdiagnosed.In this case report,we describe a patient with PI-ENKTCL who presented with intermittent hematochezia.The advantages of positron emission tomography/computed tomography(PET-CT)as a useful diagnostic tool and the role of surgery as an important therapy are highlighted.CASE SUMMARY A 45-year-old man,hospitalized due to intermittent hematochezia,underwent gastroscopy,colonoscopy,biopsy and CT,but no cause was found.Hence,we carried out a multidisciplinary team(MDT)discussion on the causes and treatment of this patient,and it was decided to perform PET-CT imaging with a MDT discussion of the results.PET-CT demonstrated a diagnosis of lymphoma and it was decided to surgically resect the lesion,and a R0 resection was successfully performed.Postoperative pathology showed negative resection margins,and examination of the lesion confirmed the diagnosis of PI-ENKTCL.After surgery,the patient underwent a follow-up period of 6 mo and received 6 cycles of gemcitabine,oxaliplatin and L-asparaginase.No recurrence or metastasis occurred.CONCLUSION PI-ENKTCL is rare,and MDT discussion is required during diagnosis.PET-CT can be performed for imaging diagnosis.Treatment is based on surgical resection,and the best treatment regimen is determined according to postoperative pathological results to improve prognosis and to extend survival in patients. 展开更多
关键词 Primary intestinal extranodal natural killer/T-cell lymphoma Multidisciplinary team discussion Rare disease Case report
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部